ALX Oncology Holdings Inc (ALXO)
16.87
+0.65
(+4.01%)
USD |
NASDAQ |
Apr 25, 16:00
16.88
+0.01
(+0.06%)
After-Hours: 20:00
ALX Oncology Holdings Price: 16.87 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 16.05 | 17.02 | 15.74 | 16.87 | 508287.0 |
Apr 24, 2024 | 15.59 | 16.25 | 15.24 | 16.22 | 441585.0 |
Apr 23, 2024 | 14.35 | 15.76 | 14.12 | 15.50 | 443830.0 |
Apr 22, 2024 | 15.60 | 15.66 | 13.88 | 14.23 | 287330.0 |
Apr 19, 2024 | 15.60 | 16.15 | 15.43 | 15.60 | 477111.0 |
Apr 18, 2024 | 16.09 | 16.15 | 15.08 | 15.74 | 667313.0 |
Apr 17, 2024 | 14.60 | 17.04 | 14.60 | 16.08 | 2.028M |
Apr 16, 2024 | 12.83 | 14.60 | 12.83 | 14.49 | 1.546M |
Apr 15, 2024 | 13.10 | 13.10 | 12.12 | 12.89 | 328161.0 |
Apr 12, 2024 | 13.32 | 13.63 | 12.51 | 13.03 | 359332.0 |
Apr 11, 2024 | 12.01 | 13.71 | 11.80 | 13.38 | 587676.0 |
Apr 10, 2024 | 12.02 | 12.23 | 11.73 | 12.05 | 458900.0 |
Apr 09, 2024 | 12.56 | 12.70 | 11.80 | 12.34 | 439595.0 |
Apr 08, 2024 | 12.42 | 12.87 | 12.10 | 12.14 | 894261.0 |
Apr 05, 2024 | 11.14 | 12.30 | 10.99 | 12.23 | 920861.0 |
Apr 04, 2024 | 11.03 | 11.29 | 10.74 | 11.24 | 300231.0 |
Apr 03, 2024 | 10.74 | 10.97 | 10.49 | 10.80 | 317561.0 |
Apr 02, 2024 | 10.74 | 10.96 | 10.55 | 10.72 | 379268.0 |
Apr 01, 2024 | 11.25 | 11.45 | 10.65 | 11.02 | 525459.0 |
Mar 28, 2024 | 11.45 | 11.45 | 10.60 | 11.15 | 1.185M |
Mar 27, 2024 | 11.61 | 11.66 | 10.95 | 11.41 | 197181.0 |
Mar 26, 2024 | 11.85 | 11.89 | 11.17 | 11.19 | 261983.0 |
Mar 25, 2024 | 11.75 | 12.17 | 11.50 | 11.72 | 268811.0 |
Mar 22, 2024 | 12.05 | 12.38 | 11.51 | 11.74 | 525141.0 |
Mar 21, 2024 | 12.24 | 12.69 | 12.04 | 12.51 | 580706.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
4.19
Minimum
Aug 28 2023
112.26
Maximum
Dec 10 2020
29.10
Average
14.66
Median
Price Benchmarks
Bristol-Myers Squibb Co | 44.70 |
Nurix Therapeutics Inc | 12.36 |
Exelixis Inc | 23.53 |
Geron Corp | 3.56 |
Verastem Inc | 9.215 |
Price Related Metrics
PS Ratio | 198.63 |
Price to Book Value | 4.460 |
Earnings Yield | -22.17% |
Market Cap | 846.07M |